Ozari Health Launches Affordable Telehealth Platform for Weight Loss Medications
Ozari Health, a telehealth company based in New York, has launched a nationwide platform to provide affordable access to GLP-1 weight loss medications. The platform offers compounded versions of Semaglutide and Tirzepatide at significantly reduced prices, starting at $86 and $120 per month, respectively. This initiative aims to make these medications accessible to a broader audience, addressing the high costs associated with brand-name versions. Patients can complete an online intake process to connect with licensed providers who evaluate their eligibility and prescribe the medications. 
